NDC 62991-2826 - Doxycycline Hyclate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62991-2826
- Package NDCs from labels
- 62991-2826-1, 62991-2826-2, 62991-2826-3, 62991-2826-4, 62991-2826-5
- Manufacturer
- LETCO MEDICAL, LLC
- Effective date
- 2022-10-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxycycline Hyclate - LETCO MEDICAL, LLC | LETCO MEDICAL, LLC | 2022-10-17 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62991-2826-3 | GM - Gram | 62991-2826 | 44656cbd-f2d3-46aa-b3c1-003c4a2cbdbe | 1 | 2013-03-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | 2023-04-10 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 6e587d8d-1a82-4dfa-acea-88704d408f2f | 2023-01-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 24c8472a-dd07-4f84-8bea-20a3f178d119 | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | ec4535a1-69f0-40a2-bcba-11afc75c721d | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE | Zydus Lifesciences Limited | 6ae11b4e-1c13-440b-a050-d76e062b0f92 | 2022-11-05 | 19XTS3T51U | |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | dd7672c9-b10f-4ea1-9000-ef3e3faa10db | 2022-09-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE | Proficient Rx LP | e2151005-fb4a-485d-88ad-b44c4594d579 | 2022-06-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 86c1f165-af79-4f01-ab61-3bdbce24cd0d | 2022-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 2993ac3d-0ec4-4230-858e-9fd00063cf57 | 2022-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 3303b423-b270-495b-9360-e43144fcf6f2 | 2021-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | b256babb-1bba-4b0c-8837-d13ba3af7659 | 2021-02-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | a7b754e2-a028-469d-ba95-8412ef03ab0a | 2021-02-02 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | b0894010-39bd-459f-8563-cf83343105ee | 2020-06-04 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Sonoma Pharmaceuticals, Inc. | 4fa26176-a730-48ed-9659-e2f64212f418 | 2018-05-23 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Novel Laboratories, Inc. | 25a92544-1421-4ccb-a49c-11742851f214 | 2018-03-12 | Warnings, Adverse reactions | 19XTS3T51U |
| Acticlate CAP | DOXYCYCLINE HYCLATE | Aqua Pharmaceuticals | 5e96d473-63dd-4446-88cf-eef2cd3339f0 | 2017-11-28 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.